The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase

Biochemical and Biophysical Research Communications

Volumn 440, Issue 2, 2013, Pages 312-316

  Shin, Jae Cheon ^a,b   Jung, Hoe Yune ^a,c   Harikishore, Amaravadhi ^d   Kwon, Oh Deog ^b   Yoon, Ho Sup ^d   Kim, Kyong Tai ^c   Choi, Bo Hwa ^a  

^a Pohang Center of Evolution of Biomaterials   (South Korea)

^b Kyungpook National University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Circadian rhythm; Locomotor activity; Melatonin; Myricetin; Serotonin N acetyltransferase

Indexed keywords

ARALKYLAMINE ACETYLTRANSFERASE; ERIOBOTRYA JAPONICA EXTRACT; MELATONIN; MYRICA RUBRA EXTRACT; MYRICETIN; PERILLA SIKOKIANA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME INHIBITION; HORMONE BLOOD LEVEL; INHIBITION KINETICS; LOCOMOTION; LOQUAT; MALE; MELATONIN BLOOD LEVEL; MOLECULAR DOCKING; MYRICA RUBRA; MYRICACEAE; NIGHT; NONHUMAN; PERILLA; PERILLA SIKOKIANA; PRIORITY JOURNAL; RAT;

CIRCADIAN RHYTHM; LOCOMOTOR ACTIVITY; MELATONIN; MYRICETIN; SEROTONIN N-ACETYLTRANSFERASE;

ANIMALS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; CIRCADIAN RHYTHM; DARKNESS; FLAVONOIDS; MALE; MELATONIN; MOTOR ACTIVITY; PLANT EXTRACTS; RATS;

ERIOBOTRYA JAPONICA; MORELLA RUBRA; PERILLA; RATTUS;

EID: 84885843972     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.076     Document Type: Article

References (37)

1. Arendt J. Melatonin and the Mammalian Pineal Gland 1995, Chapman and Hal, London.
2. Brzezinski A. Melatonin in humans. N. Engl. J. Med. 1997, 336:186-195.
3. Ellison N., Weller L., Klein D.C. Development of circadian rhythm in the activity of pineal serotonin N-acetyltransferase. Neurochemistry 1972, 19:1335-1341.
4. Krause D.N., Dubocovich M.L. Regulatory sites in the melatonin system of marnmals. Trends Neurosci. 1990, 13:464-469.
5. E. Leibenluft, Why are so many women depressed? Scientific American, 2002. Special electronic edition retrievable via. http://www.sciam.com.
6. Joffe H., Cohen L.S. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?. Biol. Psychiatry 1998, 44:798-811.
7. Kayumov L., Zhdanova I.V., Shapiro C.M. Melatonin, sleep, and circadian rhythm disorders. Semin. Clin. Neuropsychiatry 2000, 5:44-55.
8. Shinohara K., Uchiyama M., Okawa M., et al. Menstrual changes in sleep, rectal temperature and melatonin rhythms in a subject with premenstrual syndrome. Neurosci. Lett. 2000, 281:159-162.
9. Roth T. Appropriate therapeutic selection for patients with shift work disorder. Sleep Med. 2012, 13:335-341.
10. Kim T.D., Woo K.C., Cho S., et al. Rhythmic control of AANAT translation by hnRNP Q in circadian melatonin production. Genes Dev. 2007, 21:797-810.
11. Kim T.D., Kim J.S., Kim J.H., et al. Rhythmic serotonin N-acetyltransferase mRNA degradation is essential for the maintenance of its circadian oscillation. Mol. Cell. Biol. 2005, 25:3232-3246.
12. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. J. Biochem. Pharmacol. 1983, 3:1141-1148.
13. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
14. Haslam E., Lilley T.H., Ya C., et al. Traditional herbal medicine - the role of polyphenols. Planta Med. 1989, 55:1-8.
15. Kuhnau J. The flavonoids. A class of semi essential food components: the role in human nutrition. World Rev. Nutr. Diet. 1976, 24:117-121.
16. Zhang K., Das N.P. Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. J. Biochem. Pharmacol. 1994, 47(11):2063-2068.
17. Chiesi M., Schwaller R. Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. J. Biochem. Pharmacol. 1995, 49(4):495-501.
18. Divi R.L., Doerge D.R. Inhibition of thyroid peroxidase by dietary flavonoids. Chem. Res. Toxicol. 1996, 9:16-23.
19. Agullo G., Gamet-Payrastre L., Manenti S., et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. J. Biochem. Pharmacol. 1997, 53:1649-1657.
20. Choi B.H., Chae H.D., Park T.J., et al. Protein kinase C regulates the activity and stability of serotonin N-acetyltransferase. J. Neurochem. 2004, 90:442-454.
21. Borjigin J., Wang M.M., Snyder S.H. Diurnal variation in mRNA encoding serotonin N-acetyltransferase in pineal gland. Nature 1995, 378:783-785.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
23. Jones G., Willett P., Glenet R.C., et al. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267:727-748.
24. Nirmala P., Ramanathan M. Effect of myricetin on 1,2dimethylhydrazine induced rat colon carcinogenesis. J. Exp. Ther. Oncol. 2011, 9:101-108.
25. DeToma A.S., Choi J.S., Braymer J.J., et al. Myricetin: a naturally occurring regulator of metal-induced amyloid-β aggregation and neurotoxicity. ChemBioChem 2011, 16:1198-1201.
26. Liu I.M., Liou S.S., Lan T.W., et al. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2005, 71:617-621.
27. Jung S.K., Lee K.W., Kim H.Y., et al. Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. J. Biochem. Pharmacol. 2010, 15:1455-1461.
28. Redman J.R., Armstrong S.M. Reentrainment of rat circadian activity rhythms: effects of melatonin. J. Pineal Res. 1988, 5(2):203-215.
29. Slotten H.A., Pitrosky B., Pévet P. Influence of the mode of daily melatonin administration on entrainment of rat circadian rhythms. J. Biol. Rhythms 1999, 14(5):347-353.
30. Warren W.S., Hodges D.B., Cassone V.M. Pinealectomized rats entrain and phase-shift to melatonin injections in a dose-dependent manner. J. Biol. Rhythms 1993, 8(3):233-245.
31. Jan J.C., Tai J., Hahn G., et al. Melatonin replacement therapy in a child with a pineal tumor. J. Child Neurol. 2001, 16(2):139-140.
32. Lehmann E.D., Cockerell O.C., Rudge P. Somnolence associated with melatonin deficiency after pinealectomy. Lancet 1996, 347:323.
33. Smith A.C., Dykens E., Greenberg F. Sleep disturbance in Smith-Magenis syndrome. Am. J. Med. Genet. 1998, 28:186-191.
34. Klein D.C., Coon S.L., Roseboorn P.H., et al. The melatonin rhythrn-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog. Horm. Res. 1997, 52:307-358.
35. Szewczuk L.M., Saldanha S.A., Ganguly S., et al. De novo discovery of serotonin N-acetyltransferase inhibitors. J. Med. Chem. 2007, 50:5330-5338.
36. Ferry G., Ubeaud C., Mozo J., et al. New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors. Eur. J. Biochem. 2004, 271:418-428.
37. Zheng W., Cole P.A. Novel bisubstrate analog inhibitors of serotonin N-acetyltransferase: the importance of being neutral. Bioorg. Chem. 2003, 31:398-411.